• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重胰岛素抵抗综合征:临床谱与管理

Severe Insulin Resistance Syndromes: Clinical Spectrum and Management.

作者信息

Pliszka Monika, Szablewski Leszek

机构信息

Chair and Department of General Biology and Parasitology, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, Poland.

出版信息

Int J Mol Sci. 2025 Jun 13;26(12):5669. doi: 10.3390/ijms26125669.

DOI:10.3390/ijms26125669
PMID:40565151
Abstract

Insulin resistance is a condition wherein cells fail to adequately respond to insulin. It is a prevalent medical condition associated with several diseases, such as type 2 diabetes mellitus, metabolic syndrome, hypertension, obesity, and polycystic ovary syndrome. Insulin resistance may be involved in metabolic disturbances, such as hyperglycemia, hyperinsulinemia, dyslipidemia, hyperuricemia, endothelial dysfunction, elevated inflammatory markers, and a prothrombotic state. Severe insulin resistance syndromes are a heterogeneous group of rare disorders. These disorders are characterized by profound insulin resistance, substantial metabolic abnormalities, and different clinical manifestations and complications. They may be hereditary or acquired, caused by defects in insulin action and cellular responsiveness to insulin. Severe insulin resistance syndromes may also be due to aberrations in adipose tissue function and development. The majority of these disorders are associated with an increased risk of severe complications and mortality. This review aims to summarize the current knowledge on the epidemiology, pathophysiology, complications and prognosis of severe insulin resistance syndromes, as well as to categorize these syndromes by disease process, including defects in insulin receptor, intracellular insulin signaling defects, lipodystrophies, etc.

摘要

胰岛素抵抗是一种细胞无法对胰岛素产生充分反应的病症。它是一种常见的医学状况,与多种疾病相关,如2型糖尿病、代谢综合征、高血压、肥胖症和多囊卵巢综合征。胰岛素抵抗可能参与代谢紊乱,如高血糖、高胰岛素血症、血脂异常、高尿酸血症、内皮功能障碍、炎症标志物升高和血栓前状态。严重胰岛素抵抗综合征是一组异质性的罕见疾病。这些疾病的特征是严重的胰岛素抵抗、大量的代谢异常以及不同的临床表现和并发症。它们可能是遗传性的或后天获得的,由胰岛素作用缺陷和细胞对胰岛素的反应性引起。严重胰岛素抵抗综合征也可能归因于脂肪组织功能和发育异常。这些疾病中的大多数与严重并发症和死亡风险增加有关。本综述旨在总结目前关于严重胰岛素抵抗综合征的流行病学、病理生理学、并发症和预后的知识,并根据疾病过程对这些综合征进行分类,包括胰岛素受体缺陷、细胞内胰岛素信号缺陷、脂肪营养不良等。

相似文献

1
Severe Insulin Resistance Syndromes: Clinical Spectrum and Management.严重胰岛素抵抗综合征:临床谱与管理
Int J Mol Sci. 2025 Jun 13;26(12):5669. doi: 10.3390/ijms26125669.
2
Beckwith-Wiedemann Syndrome贝克威思-维德曼综合征
3
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.用于患有多囊卵巢综合征、月经过少和生育力低下的女性的胰岛素增敏药物(二甲双胍、罗格列酮、吡格列酮、D-手性肌醇)。
Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6.
4
-Related Overgrowth Spectrum相关过度生长谱系
5
Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass.代谢功能障碍相关脂肪性肝病:肌肉与体重的故事。
World J Gastroenterol. 2025 May 28;31(20):105346. doi: 10.3748/wjg.v31.i20.105346.
6
Permanent Neonatal Diabetes Mellitus永久性新生儿糖尿病
7
Diabetes Mellitus, 6q24-Related Transient Neonatal与6q24相关的短暂性新生儿糖尿病
8
Genetic Atypical Hemolytic-Uremic Syndrome遗传性非典型溶血性尿毒症综合征
9
Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.系统评价:多囊卵巢综合征与代谢综合征和非酒精性脂肪性肝病的关系。
Aliment Pharmacol Ther. 2011 Apr;33(7):801-14. doi: 10.1111/j.1365-2036.2011.04579.x. Epub 2011 Jan 20.
10
Clinical Practice Updates: AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.临床实践更新:美国胃肠病学会关于可弯曲性埃勒斯-当洛综合征的胃肠道表现及自主神经或免疫功能障碍的临床实践更新:专家综述
Clin Gastroenterol Hepatol. 2025 May 19. doi: 10.1016/j.cgh.2025.02.015.

本文引用的文献

1
The power of three: Retatrutide's role in modern obesity and diabetes therapy.三管齐下的力量:司美格鲁肽在现代肥胖症和糖尿病治疗中的作用。
Eur J Pharmacol. 2024 Dec 15;985:177095. doi: 10.1016/j.ejphar.2024.177095. Epub 2024 Nov 6.
2
Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journey.脂代谢障碍的诊断、治疗和管理:从医生角度看患者的就诊历程。
Orphanet J Rare Dis. 2024 Jul 11;19(1):263. doi: 10.1186/s13023-024-03245-3.
3
Case report: A case of Rabson-Mendenhall syndrome: long-term follow-up and therapeutic management with empagliflozin.
病例报告:1例拉布森-门登霍尔综合征病例:恩格列净的长期随访及治疗管理
Front Genet. 2024 Jun 24;15:1414451. doi: 10.3389/fgene.2024.1414451. eCollection 2024.
4
Rabson-Mendenhall Syndrome: Analysis of the Clinical Characteristics and Gene Mutations in 42 Patients.拉布森-门登霍尔综合征:42例患者的临床特征与基因突变分析
J Endocr Soc. 2024 Jun 16;8(8):bvae123. doi: 10.1210/jendso/bvae123. eCollection 2024 Jul 1.
5
A rapid action plan to improve diagnosis and management of lipodystrophy syndromes.改善脂肪营养不良综合征的诊断和管理的快速行动计划。
Front Endocrinol (Lausanne). 2024 Jun 4;15:1383318. doi: 10.3389/fendo.2024.1383318. eCollection 2024.
6
Lipodystrophy Prevalence, "Lipodystrophy-Like Phenotypes," and Diagnostic Challenges.脂肪营养不良患病率、“类脂肪营养不良表型”及诊断挑战。
Diabetes. 2024 Jul 1;73(7):1039-1042. doi: 10.2337/dbi24-0018.
7
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial.三重激素受体激动剂瑞他鲁肽治疗代谢相关脂肪性肝病:一项随机 2a 期临床试验。
Nat Med. 2024 Jul;30(7):2037-2048. doi: 10.1038/s41591-024-03018-2. Epub 2024 Jun 10.
8
"An unprecedented occurrence: a case report of pulmonary hypertension manifestation in Donohue syndrome".“史无前例的情况:Donohue 综合征表现为肺动脉高压的病例报告”。
BMC Pediatr. 2024 May 11;24(1):327. doi: 10.1186/s12887-024-04714-1.
9
A Novel Mutation in the Gene Causes Severe Insulin Resistance and Rabson-Mendenhall Syndrome in a Paraguayan Patient.一个新的基因突变导致巴拉圭患者严重胰岛素抵抗和 Rabson-Mendenhall 综合征。
Int J Mol Sci. 2024 Mar 8;25(6):3143. doi: 10.3390/ijms25063143.
10
The Changing Landscape of Neonatal Diabetes Mellitus in Italy Between 2003 and 2022.意大利 2003 年至 2022 年期间新生儿糖尿病发病情况的变化。
J Clin Endocrinol Metab. 2024 Aug 13;109(9):2349-2357. doi: 10.1210/clinem/dgae095.